Item 5. Market for Registrant’s Common Equity
ITEM 5 . MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
Our common stock is traded on the Nasdaq
Capital Market under the symbol "CLRO". As of March 31, 2026 , there were 2,675,412 shares of our common stock issued and outstanding held by approximately 288 holders of record. Each broker dealer or clearing corporation that holds shares for customers is counted as a single holder of record.
Dividends
The Company’s Board of Directors declared and paid another special dividend of $0.50 per share of the Company’s common stock and eligible warrants that was paid on April 10, 2024 to shareholders and warrant holders of record on April 2, 2024.
We do not currently anticipate paying regular cash dividends on our common stock. Any future determination regarding the declaration and payment of dividends will be at the discretion of our Board of Directors and will depend on our financial condition, results of operations, capital requirements, contractual restrictions, and other factors deemed relevant by the Board.
Issuer Purchases of Equity Securities
None.
Sales of Unregistered Securities
All sales of unregistered securities were previously reported in Forms 8-K.
Equity Compensation Plan Information.
Information about the Company’s equity compensation plans required by Item 201 (d) of Regulation S-K is set forth under Part III, Item 12 of this Annual Report on Form 10-K.
ITEM 6 . RESERVED
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.